Koomesh
Journal of Semnan University of Medical Sciences
Comparing adverse effects of docetaxel-doxorubicin and paclitaxel-doxorubicin regimens in breast cancer patients
Abstract
Copyright
© 2019, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Incidence and Cost of Chemotherapy-Induced Adverse Drug Reactions Among Cancer Patients in a Charitable Hospital
Varghese J, Mateti U, Shetty J, Philip ML, Raju BN. Incidence and Cost of Chemotherapy-Induced Adverse Drug Reactions Among Cancer Patients in a Charitable Hospital. J Rep Pharm Sci. 2021;10(1):e147100. doi: https://doi.org/10.4103/jrptps.JRPTPS_68_20
Comparison the Incidence and Severity of Side Effects Profile Of FOLFOX and DCF Regimens in Gastric Cancer Patients
Salehifar E, Avan R, Janbabaei G, Mousavi SK, Faramarzi F. Comparison the Incidence and Severity of Side Effects Profile Of FOLFOX and DCF Regimens in Gastric Cancer Patients. Iran J Pharm Res. 2019;18(2):e126242. doi: https://doi.org/10.22037/ijpr.2019.1100663
A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP
Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S. A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP. Int J Cancer Manag. 2015;8(2):e80594. doi:
Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study
Khodadad K, Khosravi A, Esfahani-Monfared Z, Karimi S, Seifi S. Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study. Iran J Pharm Res. 2014;13(2):e125542. doi: https://doi.org/10.22037/ijpr.2014.1492
Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer
Pourali L, Taghizadeh kermani A, Ghavamnasiri MR, Khoshroo F, Hosseini S, et al. Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer. Int J Cancer Manag. 2013;6(3):e80423. doi:
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 2
Last Update: 0 months ago
- Scopus by Title (Ref): 2
Last Update: 0 months ago
- CrossRef: 0
Last Update: 14 hours ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC